The first IPO of an ethanol logistics partnership is freighted with more risk than most MLPs. Read More

Government mandates for biofuel blending have caused production to soar far above free-market demand. Invest in this volatile space with extreme caution, if at all. Read More

Jim Fink’s Options Trade Performance History Jim Fink’s Private Options Service Performance 4/21/11 to 6/19/15             Underlying Stock Date Initiated and End Date (if any) Trade Duration (actual or until expiration) Investment at Risk Net Income… Read More

In this issue:In Depth:  New EBIS Buy:  Meridian Biosciences (VIVO)Portfolio Update: News on Repligen, Medivation, News Update:   Are Migraines the Next Biotech Frontier?This week we are featuring two Big Picture charts as an interesting relationship is developing between the biotech sector and the bond market.  The Nasdaq Biotech Index (NBI) delivered… Read More

Many say it's in bubble territory, but not when you consider history and cash flow. Read More

The market seems to think so. Read More

The market seems to think so. Read More

Is Facebook the perfect business model, or a disaster in the making? Read More

Some developed economies are also at risk, threatening income investors Read More

President Obama scored a major victory this week taking the Trans-Pacific Partnership (TPP) another step to becoming a reality.On Tuesday, the Senate voted 60-38 to pass fast track authority for the President, giving him the power to submit trade agreements to Congress for an up-or-down vote without amendments. That came… Read More